scispace - formally typeset
D

D. D. Gillespie

Researcher at Vanderbilt University

Publications -  24
Citations -  698

D. D. Gillespie is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Agonist & Cyclase. The author has an hindex of 14, co-authored 24 publications receiving 695 citations.

Papers
More filters
Journal ArticleDOI

Zinc and Wound Healing Effects of Zinc Deficiency and Zinc Supplementation

TL;DR: Time wounds were left open and the fractionalrate of closure determined by serial photography from a standard distance and images of the wound were projected onto white paper and the out-lines of the wounds traced and then cut out.
Journal ArticleDOI

Zinc deficiency: effect on brain of the suckling rat.

TL;DR: Zinc deficiency has been showed to impair DNA and protein synthesis in brain of the suckling rat as it has previously been shown to do in other tissues including liver and epiphyseal plate.
Journal ArticleDOI

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant

TL;DR: Evidence is provided which demonstrates that a tricyclic antidepressant can regulate steady-state mRNA levels in vivo by a mechanism which is independent of its effects on synaptic monoamine levels.
Journal ArticleDOI

Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs.

TL;DR: The results indicate that NE signal input and thus the formation of the NE‐receptor complex are prerequisites for inducing noradrenergic subsensitivity.
Journal Article

The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation.

TL;DR: Nonlinear regression analysis of competition binding curves revealed that the increase in the maximum binding of beta adrenoceptors after 5,7-DHT is due exclusively to an increase in beta adrenOceptors in the agonist low affinity conformation and that it is this receptor population that is reduced by nanomolar concentrations of 5-HT.